Twist Bioscience Corporation
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Mar 2022 | — | $863.4M | $407.6M |
| Jun 2022 | — | $820.7M | $376.2M |
| Sep 2022 | — | $789.4M | $378.7M |
| Dec 2022 | — | $746.3M | $316.7M |
| Mar 2023 | — | $703.9M | $315.2M |
| Jun 2023 | — | $657.6M | $307.5M |
| Sep 2023 | — | $623.4M | $286.5M |
| Dec 2023 | — | $590.0M | $266.3M |
| Mar 2024 | — | $560.1M | $243.3M |
| Jun 2024 | — | $491.1M | $239.1M |
| Sep 2024 | — | $472.7M | $226.3M |
| Dec 2024 | — | $455.9M | $221.4M |
| Mar 2025 | — | $440.1M | $210.4M |
| Jun 2025 | — | $478.2M | $201.4M |
| Sep 2025 | — | $473.0M | $183.0M |
| Dec 2025 | — | $456.1M | $148.6M |
| Mar 2026 | — | $455.1M | $122.7M |
| Jun 2026 | — | $445.7M | $117.4M |